Agomab Therapeutics NV Adrs (AGMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AGMB | AZN | AMGN | GILD | VRTX |
| Company | Agomab Therapeutics NV Adrs | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 12.01 | 183.40 | 348.00 | 125.56 | 471.38 |
| High | 13.77 | 184.61 | 354.42 | 127.27 | 480.86 |
| Low | 12.00 | 182.19 | 346.00 | 124.78 | 469.92 |
| Latest | 12.68 | 183.02 | 351.43 | 125.16 | 475.20 |
| Change | +0.74 | +2.00 | +4.42 | +0.11 | +6.78 |
| % Change | +6.20% | +1.10% | +1.27% | +0.09% | +1.45% |
| Volume | 199,300 | 2,377,600 | 2,391,800 | 7,409,600 | 1,549,900 |
| 20-Day Average Volume | 110,080 | 1,989,515 | 3,121,580 | 9,122,730 | 1,434,595 |
| Previous Close | 11.94 | 181.02 | 347.01 | 125.05 | 468.42 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.95 | 180.60 | 342.91 | 127.64 | 447.61 |
| 20-Day Raw Stochastic | 78.29% | 62.16% | 80.56% | 23.85% | 90.71% |
| 20-Day Relative Strength | 59.23 | 49.62 | 55.20 | 42.77 | 62.95 |
| Weighted Alpha | N/A | +22.62 | +23.30 | +7.28 | +12.32 |
| Today's Opinion | N/A | 40% Sell | 40% Buy | 72% Sell | 40% Buy |
| Previous Opinion | N/A | 56% Sell | 40% Buy | 72% Sell | 40% Buy |
| Last Month's Opinion | N/A | 8% Sell | 8% Sell | 8% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +26.80% since 06/16/26 | +2.41% since 06/16/26 | +1.03% since 06/16/26 | -1.63% since 06/16/26 | +4.86% since 06/16/26 |
| Low | 9.85 on 06/17/26 | 173.65 on 06/18/26 | 334.05 on 06/18/26 | 122.43 on 06/18/26 | 447.54 on 06/17/26 |
| High | 13.77 on 06/24/26 | 184.61 on 06/24/26 | 354.42 on 06/24/26 | 128.20 on 06/17/26 | 480.86 on 06/24/26 |
| 1-Month | |||||
| %Chg | +10.26% since 05/22/26 | -2.14% since 05/22/26 | +3.58% since 05/22/26 | -6.85% since 05/22/26 | +9.36% since 05/22/26 |
| Low | 8.75 on 06/08/26 | 173.65 on 06/18/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 13.77 on 06/24/26 | 188.72 on 05/27/26 | 358.46 on 06/11/26 | 137.20 on 05/29/26 | 480.86 on 06/24/26 |
| 3-Month | |||||
| %Chg | +8.89% since 03/24/26 | -1.49% since 03/24/26 | +0.86% since 03/24/26 | -9.38% since 03/24/26 | +5.92% since 03/24/26 |
| Low | 8.75 on 06/08/26 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 13.77 on 06/24/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 480.86 on 06/24/26 |
| 6-Month | |||||
| %Chg | N/A since 02/06/26 | -1.02% since 12/24/25 | +5.23% since 12/24/25 | -0.41% since 12/24/25 | +2.64% since 12/24/25 |
| Low | 8.75 on 06/08/26 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 17.45 on 03/03/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 432,670 | 280,745,344 | 187,284,080 | 155,258,336 | 118,887,344 |
| Shares Outstanding, K | 36,237 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -70,770,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -17,401,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | N/A | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 07/23/26 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.05 | 15.60 | 14.92 | 27.75 |